Morgan Stanley’s TriSalus Life Sciences TLSI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Buy |
56,328
+53,967
| +2,286% | +$294K | ﹤0.01% | 5679 |
|
|
2025
Q1 | $13K | Buy |
+2,361
| New | +$13K | ﹤0.01% | 6724 |
|
|
2024
Q4 | – | Sell |
-1,135
| Closed | -$5.23K | – | 8087 |
|
|
2024
Q3 | $5.23K | Sell |
1,135
-837
| -42% | -$3.86K | ﹤0.01% | 6908 |
|
|
2024
Q2 | $10.9K | Sell |
1,972
-11,337
| -85% | -$62.6K | ﹤0.01% | 6652 |
|
|
2024
Q1 | $130K | Sell |
13,309
-11,669
| -47% | -$114K | ﹤0.01% | 5889 |
|
|
2023
Q4 | $211K | Buy |
24,978
+23,841
| +2,097% | +$201K | ﹤0.01% | 5926 |
|
|
2023
Q3 | $5.82K | Buy |
+1,137
| New | +$5.82K | ﹤0.01% | 6877 |
|
|
2023
Q1 | – | Sell |
-4,050
| Closed | -$40.6K | – | 7824 |
|
|
2022
Q4 | $40.6K | Hold |
4,050
| – | – | ﹤0.01% | 6380 |
|
|
2022
Q3 | $40K | Hold |
4,050
| – | – | ﹤0.01% | 6504 |
|
|
2022
Q2 | $40K | Hold |
4,050
| – | – | ﹤0.01% | 6708 |
|
|
2022
Q1 | $40K | Hold |
4,050
| – | – | ﹤0.01% | 6808 |
|
|
2021
Q4 | $40K | Sell |
4,050
-154
| -4% | -$1.52K | ﹤0.01% | 6915 |
|
|
2021
Q3 | $42K | Buy |
4,204
+4,104
| +4,104% | +$41K | ﹤0.01% | 6795 |
|
|
2021
Q2 | $1K | Sell |
100
-125
| -56% | -$1.25K | ﹤0.01% | 7632 |
|
|
2021
Q1 | $2K | Buy |
+225
| New | +$2K | ﹤0.01% | 7284 |
|